May 7, 2025, 22:26

Emerging Scientist Grant

The Emerging Scientist Grant from Kids Beating Cancer supports graduate students and postdoctoral researchers who are committed to shaping the future of pediatric cancer research. This grant provides 10,000 USD to fund a short-term project aimed at answering a specific research question related to childhood cancers. Projects must be conducted under the supervision of a qualified mentor in the U.S.

Who is eligible?

Applicants must:

Be a graduate student (master’s, PhD, or medical degree) or a postdoctoral researcher within 2 years of receiving their degree
Be enrolled in an accredited U.S. institution with nonprofit or academic status
Work with a mentor who specializes in pediatric cancer research (mentor must be U.S.-based)
Submit original, unpublished work or significantly updated abstracts
Provide a letter of support from their mentor

Funding at a glance:

10,000 USD total
Project duration: 1–3 months
At least 80% of funds must directly support the trainee’s research involvement
Indirect costs, travel, memberships, PR, and admin expenses are not allowed

Research focus:

Projects must address a discrete, self-contained research question that fits within a broader pediatric cancer investigation. Research types can range from novel therapeutic testing in cell lines or mouse models to molecular pathway exploration in resistant cancers.

Key deadlines:

Application Deadline: June 2, 2025
Award Notification: July 1, 2025
Project Report Due: October 31, 2025

Where to apply:

All applications must be submitted through ProposalCentral using NIH-style formatting. Final reports from both trainee and mentor are required upon completion.

Questions?

Sam Azar, COO & VP of Research – [email protected]
Ian Henrich, PhD, Chair, Scientific Advisory Board – [email protected]

biomedical research cancer innovation Cancer research Childhood Cancer Early-career researchers Emerging Scientist Grant graduate research Kids Beating Cancer OncoDaily Oncology Pediatric cancer postdoctoral funding proposalCENTRAL scientific training student research

Agenus Bets Big on Botensilimab

Carlos Rodriguez-Galindo: Childhood cancer has long been overlooked in global strategies - It is time to change that

EMBER-3 Trial Updates from ESMO Breast 2025: Imlunestrant Plus Abemaciclib Improves PFS in CDK4/6i-Pretreated ER+/HER2- Breast Cancer

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research